SIRT1 activator (SRT1720) improves the follicle reserve and prolongs the ovarian lifespan of diet-induced obesity in female mice via activating SIRT1 and suppressing mTOR signaling

被引:53
|
作者
Zhou, Xiao-Ling [1 ]
Xu, Jin-Jie [2 ]
Ni, Yan-Hong [1 ]
Chen, Xiao-Chun [1 ]
Zhang, Hong-Xia [1 ]
Zhang, Xing-Mei [3 ]
Liu, Wei-Juan [1 ]
Luo, Li-Li [1 ]
Fu, Yu-Cai [2 ]
机构
[1] Shantou Univ, Affiliated Hosp 1, Dept Obstet & Gynaecol, Coll Med, Shantou 515041, Guangdong, Peoples R China
[2] Shantou Univ, Lab Cell Senescence, Coll Med, Shantou 515041, Guangdong, Peoples R China
[3] Huizhou Municipal Cent Hosp, Dept Obstet & Gynaecol, Huizhou 516001, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
SRT1720; Nicotinamide; Ovarian development; Obesity; Mice; HIGH-FAT DIET; SMALL-MOLECULE ACTIVATORS; WEIGHT-LOSS; RESVERATROL; RESTRICTION; LONGEVITY; OVULATION; PATHWAYS; PROTEIN; MODEL;
D O I
10.1186/s13048-014-0097-z
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: The prevalence of obesity is increasing worldwide and significantly affects fertility and reproduction in both men and women. Our recent study has shown that excess body fat accelerates ovarian follicle development and follicle loss in rats. The aim of the present study is to explore the effect of SIRT1 activator SRT1720 on the reserve of ovarian follicle pool and ovarian lifespan of obese mice and the underlying mechanism associated with SIRT1 and mTOR signaling. Methods: Adult female Kunming mice (n = 36) were randomly divided into three groups: the normal control (NC) group (n = 8), the caloric restriction (CR) group (fed 70% food of the NC group, n = 8) and the high-fat diet (HF) group (fed a rodent chow containing 20% fat, n = 20). After 4 months, the HF mice were further randomly divided into three groups: the control high-fat diet (CHF, n = 8) group (treated every day with an intraperitoneal injection of vehicle), the SRT1720 (SRT, n = 6) group (treated every other day with an intraperitoneal injection of SRT1720 (50 mg/kg)), the SRT1720 and nicotinamide (NAM, n = 6) group (treated every other day with an intraperitoneal injection of SRT1720 (50 mg/kg) and every day with an intraperitoneal injection of nicotinamide (100 mg/kg)). After 6 weeks of treatment, ovaries were harvested for histological and Western blotting analyses. Results: The body weight, ovary weight and visceral fat in the SRT group were significantly lower than those in the CHF group at the end of treatment. Histological analysis showed that the SRT mice had significantly greater number and percentage of primordial follicles, but lower number and percentage of corpora lutea and atretic follicles than the CHF mice and NAM mice. Western blot analysis demonstrated that the levels of SIRT1, SIRT6, FOXO3a and NRF-1 protein expression significantly increased in the ovaries of SRT mice, whereas those of mTORC1, p-mTOR, p-p70S6K, NF kappa B and p53 decreased compared to the CHF and NAM mice. Conclusions: Our study suggests that SRT1720 may improve the follicle pool reserve in HF diet-induced obese female mice via activating SIRT1 signaling and suppressing mTOR signaling, thus extending the ovarian lifespan.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] SIRT1 activator (SRT1720) improves the follicle reserve and prolongs the ovarian lifespan of diet-induced obesity in female mice via activating SIRT1 and suppressing mTOR signaling
    Xiao-Ling Zhou
    Jin-Jie Xu
    Yan-Hong Ni
    Xiao-Chun Chen
    Hong-Xia Zhang
    Xing-Mei Zhang
    Wei-Juan Liu
    Li-Li Luo
    Yu-Cai Fu
    Journal of Ovarian Research, 7
  • [2] The SIRT1 Activator SRT1720 Extends Lifespan and Improves Health of Mice Fed a Standard Diet
    Mitchell, Sarah J.
    Martin-Montalvo, Alejandro
    Mercken, Evi M.
    Palacios, Hector H.
    Ward, Theresa M.
    Abulwerdi, Gelareh
    Minor, Robin K.
    Vlasuk, George P.
    Ellis, James L.
    Sinclair, David A.
    Dawson, John
    Allison, David B.
    Zhang, Yongqing
    Becker, Kevin G.
    Bernier, Michel
    de Cabo, Rafael
    CELL REPORTS, 2014, 6 (05): : 836 - 843
  • [3] INTRAPERITONEAL INJECTION OF THE SIRT1 ACTIVATOR SRT1720 ATTENUATES THE PROGRESSION OF EXPERIMENTAL OSTEOARTHRITIS IN MICE
    Nishida, K.
    Matsushita, T.
    Takayama, K.
    Nagai, K.
    Tanaka, T.
    Inokuchi, T.
    Kirizuki, S.
    Araki, D.
    Matsumoto, T.
    Kurosaka, M.
    Kuroda, R.
    OSTEOARTHRITIS AND CARTILAGE, 2016, 24 : S359 - S360
  • [4] Intraperitoneal injection of the SIRT1 activator SRT1720 attenuates the progression of experimental osteoarthritis in mice
    Nishida, K.
    Matsushita, T.
    Takayama, K.
    Tanaka, T.
    Miyaji, N.
    Ibaraki, K.
    Araki, D.
    Kanzaki, N.
    Matsumoto, T.
    Kuroda, R.
    BONE & JOINT RESEARCH, 2018, 7 (03): : 252 - 262
  • [5] Search for a novel SIRT1 activator: Structural modification of SRT1720 and biological evaluation
    Matsuya, Yuji
    Kobayashi, Yuta
    Uchida, Sayumi
    Itoh, Yukihiro
    Sawada, Hideyuki
    Suzuki, Takayoshi
    Miyata, Naoki
    Sugimoto, Kenji
    Toyooka, Naoki
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (17) : 4907 - 4910
  • [6] SRT1720 as an SIRT1 activator for alleviating paraquat-induced models of Parkinson's disease
    Chao, Chih-Chang
    Huang, Chuen-Lin
    Cheng, Jing-Jy
    Chiou, Chun-Tang
    Lee, I-Jung
    Yang, Ying-Chen
    Hsu, Ting-Huang
    Yei, Chia-En
    Lin, Pei-Ying
    Chen, Jih-Jung
    Huang, Nai-Kuei
    REDOX BIOLOGY, 2022, 58
  • [7] The Sirt1 activator, SRT1720, attenuates renal fibrosis by inhibiting CTGF and oxidative stress
    Ren, Yunzhuo
    Du, Chunyang
    Shi, Yonghong
    Wei, Jingying
    Wu, Haijiang
    Cui, Huixian
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2017, 39 (05) : 1317 - 1324
  • [8] SRT1720, a SIRT1 activator, promotes tumor cell migration, and lung metastasis of breast cancer in mice
    Suzuki, Kensuke
    Hayashi, Ryuji
    Ichikawa, Tomomi
    Imanishi, Shingo
    Yamada, Toru
    Inomata, Minehiko
    Miwa, Toshiro
    Matsui, Shoko
    Usui, Isao
    Urakaze, Masaharu
    Matsuya, Yuji
    Ogawa, Hirofumi
    Sakurai, Hiroaki
    Saiki, Ikuo
    Tobe, Kazuyuki
    ONCOLOGY REPORTS, 2012, 27 (06) : 1726 - 1732
  • [9] The Sirt1 Activator, SRT1720, Attenuates Cardiac Hypertrophy and Fibrosis in a Rodent Pressure Overload Model
    Ford, Christopher M.
    Civitarese, Robert A.
    Bugyei-Twum, Antoinette
    Mitchell, Melissa
    Desjardins, Jean-Francois
    Thai, Kern
    Abadeh, Armin
    Zhang, Yanling
    Switzer, Jennifer
    Advani, Andrew
    Gilbert, Richard E.
    Connelly, Kim A.
    CIRCULATION, 2014, 130
  • [10] Treatment with SRT1720, a SIRT1 activator, ameliorates fatty liver with reduced expression of lipogenic enzymes in MSG mice
    Yamazaki, Yu
    Usui, Isao
    Kanatani, Yukiko
    Matsuya, Yuji
    Tsuneyama, Koichi
    Fujisaka, Shiho
    Bukhari, Agussalim
    Suzuki, Hikari
    Senda, Satoko
    Imanishi, Shingo
    Hirata, Kazuya
    Ishiki, Manabu
    Hayashi, Ryuji
    Urakaze, Masaharu
    Nemoto, Hideo
    Kobayashi, Masashi
    Tobe, Kazuyuki
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2009, 297 (05): : E1179 - E1186